Activation of a p 53-mediated Apoptotic Pathway in Quiescent Lymphocytes after the Inhibition of DNA Repair by Fludarabine 1

Purpose: The inhibition of UV-initiated DNA repair by 9-D-arabinofuranosyl-2-fluoroadenine (F-ara-A), the nucleoside of fludarabine, induces apoptosis in quiescent human lymphocytes. The sensing and signaling mechanisms after DNA repair inhibition by F-ara-A are unknown. The purpose of this study was 2-fold: (a) determine the importance of the inhibition of DNA repair processes for F-ara-A cytotoxicity and (b) identify the apoptotic signaling mechanism(s) that respond to DNA repair inhibition by F-ara-A. Experimental Design: Lymphocytes were treated with F-ara-A to accumulate the active triphosphate metabolite and subsequently DNA repair was activated by UV irradiation. Cell viability was quantitated with respect to the treatments alone and in combination to evaluate the actions of F-ara-A inhibition of DNA repair on p53 status and Fas death receptor ligand expression and function. Results: Preincubation of lymphocytes with 3 M Fara-A inhibited DNA repair initiated by 2 J/m UV and induced greater than additive apoptosis after 24 h. After equivalent repair inhibition with 0.1 M aphidicolin, there was apparently lesser p53 activation and significantly less apoptosis in irradiated lymphocytes than after 3 M Fara-A. Blocking the incorporation of F-ara-A nucleotide into repairing DNA using 30 M aphidicolin lowered the apoptotic response to that observed with aphidicolin and UV. p53 serine 15 phosphorylation and protein accumulation were detected 2 h after treatment. Fas and Fas ligand mRNA expression and protein levels increased significantly after repair inhibition. Neutralizing antibodies against Fas or Fas ligand significantly reduced apoptosis. Conclusions: These results suggest that inhibition of UVinduced DNA repair by F-ara-A is critical for cytotoxicity and that induction of apoptosis may be conducted by a p53mediated signaling mechanism to the Fas death pathway.

[1]  D. Kufe,et al.  Inhibition of c-Abl with STI571 attenuates stress-activated protein kinase activation and apoptosis in the cellular response to 1-beta-D-arabinofuranosylcytosine. , 2002, Molecular pharmacology.

[2]  W. Plunkett,et al.  DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  I. Herr,et al.  Cellular stress response and apoptosis in cancer therapy. , 2001, Blood.

[4]  D. Green,et al.  The machinery of programmed cell death. , 2001, Pharmacology & therapeutics.

[5]  R. Abraham.  Cell cycle checkpoint signaling through the ATM and ATR kinases. , 2001, Genes & development.

[6]  G. Brittinger,et al.  Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group , 2001, British journal of haematology.

[7]  H. Kantarjian,et al.  Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. Hanawalt.  Controlling the efficiency of excision repair. , 2001, Mutation research.

[9]  Y. Shiloh.  ATM and ATR: networking cellular responses to DNA damage. , 2001, Current opinion in genetics & development.

[10]  S. Elledge,et al.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. , 2000, Genes & development.

[11]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[12]  J Chen,et al.  Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage. , 2000, Cancer research.

[13]  P. Hanawalt,et al.  p53-Mediated DNA Repair Responses to UV Radiation: Studies of Mouse Cells Lacking p53, p21, and/orgadd45 Genes , 2000, Molecular and Cellular Biology.

[14]  S. Elledge,et al.  Cancer: p53 sends nucleotides to repair DNA , 2000, Nature.

[15]  Yusuke Nakamura,et al.  A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage , 2000, Nature.

[16]  J. Hoeijmakers,et al.  Nucleotide excision repair and human syndromes. , 2000, Carcinogenesis.

[17]  M. Kapoor,et al.  Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation , 2000, Oncogene.

[18]  S. Jackson,et al.  Regulation of p53 in response to DNA damage , 1999, Oncogene.

[19]  Margaret Ashcroft,et al.  Regulation of p53 stability , 1999, Oncogene.

[20]  M. Pinkoski,et al.  Fas ligand, death gene , 1999, Cell Death and Differentiation.

[21]  S. Fulda,et al.  Cytotoxic drugs and the CD95 pathway , 1999, Leukemia.

[22]  T. Burns,et al.  The p53 pathway and apoptosis , 1999, Journal of cellular physiology.

[23]  J. Roth,et al.  Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells , 1999, Oncogene.

[24]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[25]  P. Galle,et al.  The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis. , 1999, European cytokine network.

[26]  D. Israeli,et al.  p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs , 1998, The Journal of experimental medicine.

[27]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[28]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[29]  N. Dumaz,et al.  Recovery of the normal p53 response after UV treatment in DNA repair-deficient fibroblasts by retroviral-mediated correction with the XPD gene. , 1998, Carcinogenesis.

[30]  E J Freireich,et al.  Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. , 1998, Blood.

[31]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[32]  P. Hanawalt,et al.  Expression of Wild-type p53 Is Required for Efficient Global Genomic Nucleotide Excision Repair in UV-irradiated Human Fibroblasts* , 1997, The Journal of Biological Chemistry.

[33]  Zhi-Min Yuan,et al.  Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-β-D-arabinofuranosylcytosine , 1997, Oncogene.

[34]  Ralph Scully,et al.  Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage , 1997, Cell.

[35]  W. Plunkett,et al.  Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. , 1997, Cancer research.

[36]  P. Galle,et al.  Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. , 1997, The Journal of clinical investigation.

[37]  C. Sawyers,et al.  Genotoxic Drugs Induce Interaction of the c-Abl Tyrosine Kinase and the Tumor Suppressor Protein p53* , 1996, The Journal of Biological Chemistry.

[38]  W. Plunkett,et al.  Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  W. Plunkett,et al.  Inhibition of the 3′ → 5′ Exonuclease of Human DNA Polymerase ε by Fludarabine-terminated DNA* , 1996, The Journal of Biological Chemistry.

[40]  C. Harris,et al.  The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. , 1996, Genes & development.

[41]  I. Herr,et al.  Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells , 1996, Nature Medicine.

[42]  P. Mclaughlin,et al.  Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  J. Roth,et al.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.

[44]  P. J. Abrahams,et al.  Different regulation of p53 stability in UV-irradiated normal and DNA repair deficient human cells. , 1995, Mutation research.

[45]  K. Bhalla,et al.  1-β-d-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation , 1994, Cancer Chemotherapy and Pharmacology.

[46]  K. Sakaguchi,et al.  Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.

[47]  R. Sheaff,et al.  Mechanism of DNA polymerase alpha inhibition by aphidicolin. , 1991, Biochemistry.

[48]  D. Kufe,et al.  Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine. , 1991, Cancer research.

[49]  W. Plunkett,et al.  Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity. , 1990, The Journal of biological chemistry.

[50]  D. Kufe,et al.  Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA. , 1986, Biochemical pharmacology.

[51]  R. Weichselbaum,et al.  Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair. , 1984, Molecular pharmacology.

[52]  R. W. Brockman,et al.  In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. , 1982, Molecular pharmacology.

[53]  J. Robbins,et al.  Cockayne's syndrome fibroblasts have increased sensitivity to ultraviolet light but normal rates of unscheduled DNA synthesis. , 1978, The Journal of investigative dermatology.

[54]  J. Robbins,et al.  Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[55]  K. Kraemer,et al.  Colony-forming ability of ultraviolet-irradiated xeroderma pigmentosum fibroblasts from different DNA repair complementation groups. , 1976, Biochimica et biophysica acta.

[56]  Peng Huang,et al.  Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event , 2004, Cancer Chemotherapy and Pharmacology.

[57]  R. Moses.  DNA damage processing defects and disease. , 2001, Annual review of genomics and human genetics.

[58]  M. Lutter,et al.  Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.

[59]  Wei Zhang,et al.  Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment , 1998, Cell Death and Differentiation.

[60]  R. Wood.  DNA repair in eukaryotes. , 1996, Annual review of biochemistry.

[61]  A. Sancar.  DNA excision repair. , 1996, Annual review of biochemistry.